UPDATE: Goldman Sachs Downgrades Adtran to Sell
According to Goldman Sachs, Adtran (NASDAQ: ADTN) is downgraded to Sell.
Goldman Sachs said that it is downgrading Adtran to Sell from Neutral, with 14% downside to its $29, 12-month price target. “There is no change to our estimates or to our 12-month price target of $29, based on 14X our CY2012 EPS estimate of $2.07.”
Adtran closed yesterday at $33.83.







